- Joined
- 21 November 2023
- Posts
- 12
- Reactions
- 27
Its straight to the point answers like this that I'm looking for. I knew there was a valid reason.
IMU - Imugene Limited
- Thread starter yogi-in-oz
- Start date
-
- Tags
- imu imugene limited
- Joined
- 21 November 2023
- Posts
- 12
- Reactions
- 27
Is that the reason why the price has jumped 7% on the 27/11/2023?
Has everyone got their bonuses at the same time, and all decided to put it into IMU? Have they all waited for this day in particular to buy a position?
I was more so asking what has happened today that has caused a rise...
When looking at a 7% rise with no immediate recent announcements. Do you just go back and assume that it is from the announcement from the start of the month?
BTW its a 10% rise now...
- Joined
- 21 November 2023
- Posts
- 12
- Reactions
- 27
I think you've caught me out here...
No i haven't read it, but from now on if i see a report with a recommendation i will read it.
M
Sean K
Moderator
- Joined
- 21 April 2006
- Posts
- 22,304
- Reactions
- 11,583
Iggy picked it in the monthly comp. Immediate response.
Could have been the RIH dart team too.
Or, maybe the CF33 study?
Has come off a bit...
- Joined
- 12 January 2008
- Posts
- 7,348
- Reactions
- 18,345
@MDWake Check out the recent corporate news releases for reasons why the price has spiked.
Align the dates of the news with the price bars.
Positive early signs in a drug trial will tempt both speculators and investors causing an excess demand over supply.
Align the dates of the news with the price bars.
Positive early signs in a drug trial will tempt both speculators and investors causing an excess demand over supply.
- Joined
- 28 May 2004
- Posts
- 10,893
- Reactions
- 5,389
A couple of things:
1. The two threads on IMU have now been merged.
2. Some off topic posts have been removed.
Let's please get back to discussing IMU. Thanks everyone.
1. The two threads on IMU have now been merged.
2. Some off topic posts have been removed.
Let's please get back to discussing IMU. Thanks everyone.
- Joined
- 8 March 2007
- Posts
- 2,890
- Reactions
- 3,995
What Can I I Say ?
What a Beauty !
All I Can Say is that Heads are Going to Roll on my Ship at Dawn
What a Beauty !
All I Can Say is that Heads are Going to Roll on my Ship at Dawn
Dona Ferentes
Pengurus pengatur
- Joined
- 11 January 2016
- Posts
- 16,351
- Reactions
- 22,333
looking to open higher in further news. There's a steady flow
• FDA Fast Track Designation for Bile Duct Cancer granted for CF33-hNIS (VAXINIA) MAST Clinical Program
• FDA’s Fast Track Designation for CF33-hNIS (VAXINIA) offers closer cooperation with the FDA to expedite the MAST clinical program and subsequent potential approval process
• Fast Track provides eligibility for Accelerated Approval and Priority Review
• Imugene will utilise the Fast Track designation to work with the FDA on advancing this important drug program towards patients on an accelerated timeline
• FDA Fast Track Designation for Bile Duct Cancer granted for CF33-hNIS (VAXINIA) MAST Clinical Program
• FDA’s Fast Track Designation for CF33-hNIS (VAXINIA) offers closer cooperation with the FDA to expedite the MAST clinical program and subsequent potential approval process
• Fast Track provides eligibility for Accelerated Approval and Priority Review
• Imugene will utilise the Fast Track designation to work with the FDA on advancing this important drug program towards patients on an accelerated timeline
IMU hit a low share price a couple of months ago. This was partly due to the market not liking companies with no revenue and partly by quite a few shareholders not understanding why multiple fundraisings have occurred and not understanding the amazing product that IMU has purchased with the last fundraise.
The ducks are all lined up now and some amazing trial results are expected over this next year. Results from some recent trials and these forthcoming trials will indicate IMU as a serious contended to kill a range of cancers, including solid cancers.
The ducks are all lined up now and some amazing trial results are expected over this next year. Results from some recent trials and these forthcoming trials will indicate IMU as a serious contended to kill a range of cancers, including solid cancers.
- Joined
- 21 August 2008
- Posts
- 2,831
- Reactions
- 8,769
Should one of these threads be removed from the selection list @Joe Blow since they have been merged ?
- Joined
- 21 August 2008
- Posts
- 2,831
- Reactions
- 8,769
IMU is one of my selections in the 2024 CY Comp. All my selections are made from a scan and flicking through charts.
@access in the post above makes some good points about IMU which gives me more hope to go along with what I'm seeing when looking at the chart.
Has the downtrend finished yet, I hope so but I might be getting in a little early on this.
The MAs are heading in the right direction at the moment and price is above them at the moment so that's good.
@access in the post above makes some good points about IMU which gives me more hope to go along with what I'm seeing when looking at the chart.
Has the downtrend finished yet, I hope so but I might be getting in a little early on this.
The MAs are heading in the right direction at the moment and price is above them at the moment so that's good.
- Joined
- 2 May 2007
- Posts
- 4,733
- Reactions
- 2,981
IMU is a stock I have held for some months with pride and sold with some profit.
I do believe this has an excellent future primarily driven by some exciting news published on ASX, the topic of research, competitveness and advanced stage of progress.
The following extract is to be understood as days and months to go in 2024.
On 11 Jan the presentation would let the world know many more and wait and see
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02750496-3A632641 - THIS IS A GREAT NEWS. Phase 2
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02750417-3A632617 - this has the element of human benefits in terms of oncology side and $$$ for investor perspective.
market cap is only $752 M and massive cash $104M to carry forward probably Phase 3 for some of its products, for such a sleeping giant
the one year road map of progression is great. There could be some serious ups or downs in Q4 2024.
I do believe this has an excellent future primarily driven by some exciting news published on ASX, the topic of research, competitveness and advanced stage of progress.
The following extract is to be understood as days and months to go in 2024.
On 11 Jan the presentation would let the world know many more and wait and see
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02750496-3A632641 - THIS IS A GREAT NEWS. Phase 2
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02750417-3A632617 - this has the element of human benefits in terms of oncology side and $$$ for investor perspective.
market cap is only $752 M and massive cash $104M to carry forward probably Phase 3 for some of its products, for such a sleeping giant
the one year road map of progression is great. There could be some serious ups or downs in Q4 2024.
- Joined
- 21 August 2008
- Posts
- 2,831
- Reactions
- 8,769
2024 Comp January Update:
Only very early in the year and IMU price hasn't moved much and no sellers are dumping stock at the moment so that's a good sign.
I did notice a ASX Announcement on the 10/1/2024 titled Imugene Presentation to JPMorgan Healthcare Conference.
Hopefully this might bring on some large volume on buying in the near future, once digested.
www.marketindex.com.au
Only very early in the year and IMU price hasn't moved much and no sellers are dumping stock at the moment so that's a good sign.
I did notice a ASX Announcement on the 10/1/2024 titled Imugene Presentation to JPMorgan Healthcare Conference.
Hopefully this might bring on some large volume on buying in the near future, once digested.
IMU:ASX Announcement - Imugene Presentation to JPMorgan Healthcare Conference - 10 Jan 2024
Read IMU's full ASX announcement titled "Imugene Presentation to JPMorgan Healthcare Conference" from 10 Jan 2024, on Market Index.
www.marketindex.com.au
- Joined
- 2 May 2007
- Posts
- 4,733
- Reactions
- 2,981
For the benefit of those not read the presentation2024 Comp January Update:
Only very early in the year and IMU price hasn't moved much and no sellers are dumping stock at the moment so that's a good sign.
I did notice a ASX Announcement on the 10/1/2024 titled Imugene Presentation to JPMorgan Healthcare Conference.
Hopefully this might bring on some large volume on buying in the near future, once digested.
IMU:ASX Announcement - Imugene Presentation to JPMorgan Healthcare Conference - 10 Jan 2024
Read IMU's full ASX announcement titled "Imugene Presentation to JPMorgan Healthcare Conference" from 10 Jan 2024, on Market Index.
- Joined
- 21 August 2008
- Posts
- 2,831
- Reactions
- 8,769
ASX Announcement this morning for IMU.
For the full document I have attached the link below:
www.marketindex.com.au
For the full document I have attached the link below:
Market Index - ASX Stock Quotes, Charts & Analysis
Complete overview of the ASX share market. Get today's stock quotes, tips, broker consensus and upcoming floats.
www.marketindex.com.au
- Joined
- 21 August 2008
- Posts
- 2,831
- Reactions
- 8,769
Announcement from IMU - 15 February 2024
Link below:
www.marketindex.com.au
Phase 1 onCARlytics Trial Doses First Intravenous Patient
Phase 1 onCARlytics trial doses first patient in intravenous monotherapy armLink below:
Market Index - ASX Stock Quotes, Charts & Analysis
Complete overview of the ASX share market. Get today's stock quotes, tips, broker consensus and upcoming floats.
www.marketindex.com.au
Sean K
Moderator
- Joined
- 21 April 2006
- Posts
- 22,304
- Reactions
- 11,583
I have a feeling these guys only need to hit the dart board once with these trials and they'll go bananas. Maybe a TO target for someone like CSL. Will be an interesting year.
- Joined
- 2 May 2007
- Posts
- 4,733
- Reactions
- 2,981
IMU, my 2024 tip. @debtfree - fulfilling the condition of one minimum posting per month 
I am very positive on IMU future and surely by the end of Nov 24.
Not just wish but based on recommendations, company report and also seeing what stock specialists chart predict its performance as a strong buy
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02768426-3A635633 DIRECTOR TRANSACTION
I am very positive on IMU future and surely by the end of Nov 24.
Not just wish but based on recommendations, company report and also seeing what stock specialists chart predict its performance as a strong buy
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02768426-3A635633 DIRECTOR TRANSACTION
Attachments
IMU currently have 5 possible cancer cures in development trials and all are progressing as well as expected.
One of these trials is for Vaxinia. FDA are so impressed with the trial so far that in Nov '23 they provided Fast Track approval for the trial.
The success rates for Fast Track applications submitted to the FDA's Center for Drug Evaluation and Research (CDER) range between 70% and 80%.
So IMU are in regular communication with the FDA and, as IMU are treating a type of cancer that is not treatable at present, could possibly have trials finish earlier than normal if FDA are satified with results. IMU can then use this product treatment to then cross-over to treat other types of cancer with FDA consent.
A big year coming up.
One of these trials is for Vaxinia. FDA are so impressed with the trial so far that in Nov '23 they provided Fast Track approval for the trial.
The success rates for Fast Track applications submitted to the FDA's Center for Drug Evaluation and Research (CDER) range between 70% and 80%.
So IMU are in regular communication with the FDA and, as IMU are treating a type of cancer that is not treatable at present, could possibly have trials finish earlier than normal if FDA are satified with results. IMU can then use this product treatment to then cross-over to treat other types of cancer with FDA consent.
A big year coming up.
